This statistic highlights Bionano Genomics’ Revenue by Region from Q1 2018 onwards, split between the Asia Pacific, Europe, Middle East, India, and Africa, and North America.
This statistic highlights Gilead Sciences’ Revenue Breakdown Worldwide from Q1 2016 onwards, split between Europe, Other International, and United States, reported on a quarterly basis.
This article discusses Fulgent Genetics’ Revenue Breakdown, across Institutional, Patient, and Insurance segments, from 2018 onwards.
This statistic highlights Johnson & Johnson’s Revenue by Region, split between Asia-Pacific, Africa, Europe and the United States.
This statistic covers Johnson & Johnson’s Revenue Breakdown, split across Consumers, Medical Devices, and Pharmaceutical from 2016 onwards.
This statistic highlights Novavax’s Revenue by Segment from 2016 onwards, split between Government contracts and Grant and others.
This statistic highlights United Healthcare’s Revenue Breakdown from Q1 2016 onwards, split across Investment and other income, Premiums, Products, and Services, on a quarterly basis.
This chart highlights CVS’ Revenue Breakdown, split between Premiums, Products, and Services, from 2019 onwards.
This statistic highlights United Healthcare’s Revenue by Segment from 2016 onwards, split between OptumHealth, OptumInsight, OptumRx, and UnitedHealthcare.
This statistic highlights CVS’ Revenue By Segment split across Pharmacy Services, Health Care Benefits, Retail/LTC, and other segments, from 2016 onwards
